Amarin Corp Plc (AMRN)

[ilovetech]

Tuca., thanks. Lovaza has a predictable sales floor of 63,000 give or take.

I'll state it a second time, I would have announced an "authorized generic" the day after the DC decision. It would have given generics REASON TO PAUSE and re-evaluate their strategy. If I'm generics, I'd have to consider, "what is the circumstantial threshold," that would stop us from entering the market? What is the risk of launching into a pool of pariahs? How can we guage the potential rewards of off-label sales to justify the endeaver, especially into a market "we single handedly prevented from developing."

Talk about biting your nose to spite your face!

ILT